Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort. (Q48331810)

10 February 2018

title

Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort. (English)

1 reference

10 February 2018

mild cognitive impairment

0 references

0 references

1 reference

1 reference

1 reference

cognitive dysfunction

1 reference

I Blasko

1

1 reference

10 February 2018

M Hinterberger

2

1 reference

10 February 2018

G Kemmler

3

1 reference

10 February 2018

S Jungwirth

4

1 reference

10 February 2018

W Krampla

5

1 reference

10 February 2018

T Leitha

6

1 reference

10 February 2018

K Heinz Tragl

7

1 reference

10 February 2018

P Fischer

8

1 reference

10 February 2018

publication date

1 August 2012

1 reference

10 February 2018

The Journal of Nutrition, Health and Aging

published in

1 reference

10 February 2018

volume

16

1 reference

10 February 2018

issue

8

1 reference

10 February 2018

page(s)

687-694

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s12603-012-0051-y

exact match

0 references

cites work

Homocysteine and brain atrophy

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Brain function in the elderly: role of vitamin B12 and folate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

The worldwide challenge of the dementias: a role for B vitamins and homocysteine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Conversion from subtypes of mild cognitive impairment to Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Outcomes of mild cognitive impairment by definition: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Frequency and course of mild cognitive impairment in a multiethnic community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Relation of higher folate intake to lower risk of Alzheimer disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Do the effects of APOE-ε4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Homocysteine and B vitamins in mild cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Sex differences in the causes and consequences of white matter hyperintensities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Plasma vitamin B12 status and cerebral white-matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Answering autobiographical questions: the impact of memory and inference on surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-012-0051-Y

Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

12 December 2020

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

12 December 2020

B vitamins, homocysteine, and neurocognitive function in the elderly

1 reference

12 December 2020

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

12 December 2020

VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly.

1 reference

12 December 2020

Vienna Transdanube Aging "VITA": study design, recruitment strategies and level of participation.

1 reference

12 December 2020

CT evaluation of the CSF spaces of healthy persons

1 reference

12 December 2020

Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people

1 reference

12 December 2020

Magnetic resonance measures in Alzheimer disease: their utility in early diagnosis and evaluating disease progression.

1 reference

12 December 2020

Association between nutritional status and cognitive functioning in a healthy elderly population.

1 reference

12 December 2020

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

1 reference

12 December 2020

Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study.

1 reference

12 December 2020

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial

1 reference

12 December 2020

Clinical chemistry reference values for 75-year-old apparently healthy persons

1 reference

12 December 2020

10.1007/S12603-012-0051-Y

Identifiers

DOI

1 reference

10 February 2018

release_rajd6nepfvbyropnqnfig27n6e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rajd6nepfvbyropnqnfig27n6e

24 November 2022

mapped directly with Wikidata item

PubMed ID

23076510

1 reference

10 February 2018